Skip to main content
Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.958
+0.030 (3.21%)
At close: Dec 20, 2024, 4:00 PM
1.000
+0.042 (4.40%)
After-hours: Dec 20, 2024, 7:15 PM EST

Kronos Bio Revenue

Kronos Bio had revenue of $2.37M in the quarter ending September 30, 2024, with 158.45% growth. This brings the company's revenue in the last twelve months to $9.86M, up 146.48% year-over-year. In the year 2023, Kronos Bio had annual revenue of $6.29M.

Revenue (ttm)
$9.86M
Revenue Growth
+146.48%
P/S Ratio
5.78
Revenue / Employee
$156,571
Employees
63
Market Cap
57.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20236.29M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareCloud 111.01M
Spero Therapeutics 106.46M
Repare Therapeutics 66.52M
Dyadic International 3.36M
VolitionRx 1.29M
Revenue Rankings

KRON News

More News